BRPI0510335A - composto heterocìclico - Google Patents

composto heterocìclico

Info

Publication number
BRPI0510335A
BRPI0510335A BRPI0510335-5A BRPI0510335A BRPI0510335A BR PI0510335 A BRPI0510335 A BR PI0510335A BR PI0510335 A BRPI0510335 A BR PI0510335A BR PI0510335 A BRPI0510335 A BR PI0510335A
Authority
BR
Brazil
Prior art keywords
ring
heterocyclic compound
alkyl
heterocyclic group
imidazolin
Prior art date
Application number
BRPI0510335-5A
Other languages
English (en)
Inventor
Akira Kubo
Tetsu Nakane
Tatsuo Nakajima
Takanori Murakami
Hidetaka Miyoshi
Akihito Ogasawara
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BRPI0510335A publication Critical patent/BRPI0510335A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

COMPOSTO HETEROCìCLICO. A presente invenção refere-se proporcionar um novo composto heterocíclico da fórmula ¢I!: em que R¬ 1¬ é um halogênio, nitro, uma alquila, etc.; R¬ 2¬ é hidrogênio, uma alquila, etc.; Anel A é 2-oxo-4-imidazolin-3,4-diila, etc.; Anel B é um cicloalquila, grupo heterocíclico saturado monocíclico; X é CH, N; Y é uma ligação única, CO, SO~ 2~; Z é O, NH, etc.; e Anel C é uma arila, um grupo heterocíclico, ou um sal farmaceuticamente aceitável do mesmo, o qual é útil como um inibidor da p38 MAR quinase.
BRPI0510335-5A 2004-04-28 2005-04-28 composto heterocìclico BRPI0510335A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004133204 2004-04-28
US56608904P 2004-04-29 2004-04-29
JP2005007832 2005-01-14
PCT/JP2005/008564 WO2005105790A1 (en) 2004-04-28 2005-04-28 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
BRPI0510335A true BRPI0510335A (pt) 2007-10-23

Family

ID=43384198

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510335-5A BRPI0510335A (pt) 2004-04-28 2005-04-28 composto heterocìclico

Country Status (12)

Country Link
US (1) US7700771B2 (pt)
EP (1) EP1740578B1 (pt)
JP (1) JP2007535476A (pt)
AT (1) ATE491704T1 (pt)
AU (1) AU2005238390C1 (pt)
BR (1) BRPI0510335A (pt)
CA (1) CA2563042C (pt)
DE (1) DE602005025332D1 (pt)
MY (1) MY143245A (pt)
NO (1) NO20064175L (pt)
TW (1) TWI326282B (pt)
WO (1) WO2005105790A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113481A1 (en) * 2003-12-17 2010-05-06 Alcon Research, Ltd. Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
DE102009043260A1 (de) 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
DE102009049679A1 (de) 2009-10-19 2011-04-21 Merck Patent Gmbh Pyrazolopyrimidinderivate
DE102010049595A1 (de) 2010-10-26 2012-04-26 Merck Patent Gmbh Chinazolinderivate
KR20140072177A (ko) * 2011-10-06 2014-06-12 바이엘 인텔렉쳐 프로퍼티 게엠베하 헤테로사이클릴피리(미)디닐피라졸
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
AR016294A1 (es) 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
EP1021173A1 (en) * 1997-10-10 2000-07-26 Imperial College Innovations Limited Use of csaid?tm compounds for the management of uterine contractions
CO5170501A1 (es) * 1999-04-14 2002-06-27 Novartis Ag AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO
US6492516B1 (en) * 1999-05-14 2002-12-10 Merck & Co., Inc. Compounds having cytokine inhibitory activity
PL366110A1 (en) 1999-08-13 2005-01-24 Vertex Pharmaceuticals Incorporated Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
WO2001091749A1 (en) * 2000-06-01 2001-12-06 Merck & Co., Inc. Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors
PE20020506A1 (es) * 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
HUP0401949A3 (en) * 2001-10-22 2009-07-28 Mitsubishi Tanabe Pharma Corp 4-imidazolin-2-one derivatives
EP1511743A1 (en) * 2002-06-05 2005-03-09 Pharmacia Corporation Pyrazole-derivatives as p38 kinase inhibitors
AU2003242873A1 (en) 2002-06-06 2003-12-22 Koninklijke Philips Electronics N.V. Quad flat non-leaded package comprising a semiconductor device
MXPA05012377A (es) * 2003-05-15 2006-05-25 Arqule Inc Derivados de imidazotiazoles e imidazoxazol como inhibidores de p38.

Also Published As

Publication number Publication date
NO20064175L (no) 2006-12-13
ATE491704T1 (de) 2011-01-15
JP2007535476A (ja) 2007-12-06
EP1740578B1 (en) 2010-12-15
DE602005025332D1 (de) 2011-01-27
AU2005238390B2 (en) 2009-01-08
US7700771B2 (en) 2010-04-20
MY143245A (en) 2011-04-15
CA2563042C (en) 2010-04-27
AU2005238390A1 (en) 2005-11-10
CA2563042A1 (en) 2005-11-10
WO2005105790A1 (en) 2005-11-10
TWI326282B (en) 2010-06-21
EP1740578A1 (en) 2007-01-10
US20070185326A1 (en) 2007-08-09
AU2005238390C1 (en) 2009-06-25
TW200536843A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
NO20064175L (no) Heterosyklisk forbindelse
TW200611907A (en) Fused heterocyclic compound
TW200740820A (en) Fused heterocyclic derivatives and use thereof
TW200633991A (en) Chemical compounds
JO2791B1 (en) Acid secretion inhibitor
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
NO20080761L (no) Acykliske Ikur inhibitorer
DK1755606T3 (da) Quinazolinonderivater, der er anvendelige som vanilloid-antagonister
AR053662A1 (es) Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
EA200200446A1 (ru) НОВЫЕ α-АМИНОКИСЛОТНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ
WO2006109075A3 (en) Hydroxybenzamide derivatives and their use as inhibitors of hsp90
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
ATE553077T1 (de) Peptidaseinhibitoren
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
AR055666A1 (es) Inhibidores inntr
NO20052023L (no) Kalsium aktivert K kanal apner med hoy konduktans
TW200616997A (en) The preparation method for 6-substituted-1-methyl-1h-benzoimidazol derivatives and their preparation imtermediates
MX2007001952A (es) Compuestos y composiciones utiles como inhibidores de catepsina-s.
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
TH92456B (th) สารประกอบเฮเทอโรไซคลิค
TH92456A (th) สารประกอบเฮเทอโรไซคลิค

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MITSUBISHI TANABE PHARMA CORPORATION (JP)

Free format text: ALTERADO DE: TANABE SEIYAKU CO., LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.